These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3522912)

  • 21. Prenatal diagnosis of cystic fibrosis in South Africa.
    Nelson MM; Berman PA; Davidson JS; Petersen EM
    S Afr Med J; 1984 Nov; 66(18):688-90. PubMed ID: 6149625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitive trypsin assay for dried-blood specimens as a screening procedure for early detection of cystic fibrosis.
    King DN; Heeley AF; Walsh MP; Kuzemko JA
    Lancet; 1979 Dec; 2(8154):1217-9. PubMed ID: 92625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prenatal diagnosis of cystic fibrosis by analysis of microvillar enzymes of the amniotic fluid].
    Szabó M; Teichmann F; Huszka M; Münnich A; Veress L; Papp Z
    Orv Hetil; 1990 Aug; 131(32):1749-50, 1753-5. PubMed ID: 2205827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for cystic fibrosis.
    Dodge JA; Ryley HC
    Arch Dis Child; 1982 Oct; 57(10):774-80. PubMed ID: 7138066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amniotic fluid calcium concentration in the prenatal diagnosis of cystic fibrosis.
    Dann LG; Baker S; Grinham C; Blau K
    Prenat Diagn; 1983; 3(2):161-3. PubMed ID: 6622396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy screening for cystic fibrosis.
    Young ID
    Lancet; 1993 Sep; 342(8871):569-70. PubMed ID: 8102716
    [No Abstract]   [Full Text] [Related]  

  • 27. Amplification refractory mutation system for prenatal diagnosis and carrier assessment in cystic fibrosis.
    Newton CR; Heptinstall LE; Summers C; Super M; Schwarz M; Anwar R; Graham A; Smith JC; Markham AF
    Lancet; 1989 Dec 23-30; 2(8678-8679):1481-3. PubMed ID: 2574768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microvillar enzymes in amniotic fluid. Considerations for the prenatal diagnosis of cystic fibrosis.
    Carey WF; Pollard AC
    Med J Aust; 1986 Jan; 144(2):68-71. PubMed ID: 2417095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carrier screening for cystic fibrosis: a perinatal perspective.
    Demsey SA
    J Perinat Neonatal Nurs; 1999 Sep; 13(2):14-26. PubMed ID: 10818851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA probes or microvillar enzymes or both for prenatal diagnosis of cystic fibrosis.
    Brock DJ
    J Med Genet; 1986 Aug; 23(4):376. PubMed ID: 3746848
    [No Abstract]   [Full Text] [Related]  

  • 31. Prenatal diagnosis of cystic fibrosis.
    Mastella G; Perobelli S; Borgo G
    Lancet; 1985 Sep; 2(8454):554. PubMed ID: 2863570
    [No Abstract]   [Full Text] [Related]  

  • 32. Prenatal genetics: the evolution and future directions of screening and diagnosis.
    Slack C; Lurix K; Lewis S; Lichten L
    J Perinat Neonatal Nurs; 2006; 20(1):93-7. PubMed ID: 16508474
    [No Abstract]   [Full Text] [Related]  

  • 33. Prenatal diagnosis of cystic fibrosis: false negative result with the 4-methylumbelliferyl-p-guanidinobenzoate assay for proteases in amniotic fluid.
    Green JR; Lentze MJ; Rossi E; Sidiropoulos D; Schubiger G
    Eur J Pediatr; 1982 Sep; 139(1):35-8. PubMed ID: 6756926
    [No Abstract]   [Full Text] [Related]  

  • 34. Peptidases in amniotic fluid: low values in cystic fibrosis.
    Baker S; Dann LG
    Lancet; 1983 Mar; 1(8326 Pt 1):716-7. PubMed ID: 6132078
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening for cystic fibrosis.
    Roderick PJ; Chapple J
    Lancet; 1989 Dec; 2(8676):1403-4. PubMed ID: 2574354
    [No Abstract]   [Full Text] [Related]  

  • 36. Transient neonatal hypertrypsinaemia as test for delta F508 heterozygosity.
    Lucotte G; Perignon JL; Lenoir G
    Lancet; 1991 Apr; 337(8747):988. PubMed ID: 1678079
    [No Abstract]   [Full Text] [Related]  

  • 37. The impact of a national population carrier screening program on cystic fibrosis birth rate and age at diagnosis: Implications for newborn screening.
    Stafler P; Mei-Zahav M; Wilschanski M; Mussaffi H; Efrati O; Lavie M; Shoseyov D; Cohen-Cymberknoh M; Gur M; Bentur L; Livnat G; Aviram M; Alkrinawi S; Picard E; Prais D; Steuer G; Inbar O; Kerem E; Blau H
    J Cyst Fibros; 2016 Jul; 15(4):460-6. PubMed ID: 26386752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum-immunoreactive-trypsin concentrations in cystic fibrosis.
    Dandona P; Hodson M; Bell J; Ramdial L; Batten JC
    Lancet; 1979 May; 1(8124):1032. PubMed ID: 86747
    [No Abstract]   [Full Text] [Related]  

  • 39. Reaction of 4-methylumbelliferylguanidinobenzoate with proteases in human amniotic fluid.
    Walsh MM; Rao GJ; Nadler HL
    Pediatr Res; 1980 Apr; 14(4 Pt 1):353-6. PubMed ID: 6990368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal screening for cystic fibrosis.
    Phelan PD
    Thorax; 1995 Jul; 50(7):705-6. PubMed ID: 7570400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.